Reports for SUN PHARMA CANADA INC
Company Name
SUN PHARMA CANADA INC
Totals |
||
Shortage reports |
359 |
|
| Actual shortage: | 30 (8%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 6 (2%) | |
| Resolved: | 323 (90%) | |
Discontinuation Reports |
33 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 33 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
208 (53%) |
|
Overdue reports |
15 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-RISPERIDONE | 0.5MG | TABLET | Resolved | 2019-06-24 | 2019-07-06 | 87391 |
| TARO-RISPERIDONE | 0.5MG | TABLET | Resolved | 2019-11-08 | 2019-12-13 | 98309 |
| TARO-RISPERIDONE | 0.5MG | TABLET | Resolved | 2020-12-03 | 2021-02-14 | 129539 |
| TARO-RISPERIDONE | 0.5MG | TABLET | Resolved | 2021-10-13 | 2022-08-19 | 147095 |
| TARO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2019-11-26 | 2020-01-04 | 99775 |
| TARO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2020-07-03 | 2020-08-28 | 119411 |
| TARO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2020-12-03 | 2021-05-01 | 129544 |
| TARO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2021-01-31 | 2021-05-01 | 132970 |
| TARO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2019-05-28 | 2019-07-06 | 85081 |
| TARO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2020-01-04 | 2020-02-02 | 102266 |
| TARO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2021-01-31 | 2021-05-01 | 132973 |
| TARO-RISPERIDONE | 3.0MG | TABLET | Resolved | 2019-08-06 | 2019-08-19 | 90767 |
| TARO-RISPERIDONE | 4.0MG | TABLET | Resolved | 2020-01-04 | 2020-08-28 | 102269 |
| TARO-RISPERIDONE | 4.0MG | TABLET | Resolved | 2021-01-31 | 2021-06-16 | 132976 |
| TARO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2017-05-10 | 2018-11-28 | 9992 |
| TARO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2019-02-11 | 2019-05-29 | 75277 |
| TARO-ROSUVASTATIN | 5MG | TABLET | Resolved | 2019-02-11 | 2019-05-28 | 75280 |
| TARO-ROSUVASTATIN | 10MG | TABLET | Resolved | 2017-05-16 | 2019-02-04 | 10530 |
| TARO-ROSUVASTATIN | 20MG | TABLET | Resolved | 2017-05-05 | 2019-02-01 | 9236 |
| TARO-ROSUVASTATIN | 40MG | TABLET | Avoided shortage | 2017-09-12 | 2019-02-04 | 21961 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-AMLODIPINE | 5MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115038 |
| TARO-AMLODIPINE | 5MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115046 |
| TARO-AMLODIPINE | 10MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115049 |
| TARO-AMLODIPINE | 10MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115052 |
| TARO-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115059 |
| TARO-CLARITHROMYCIN | 500MG | TABLET | Discontinued | 2020-02-02 | 2020-02-02 | 105091 |
| TARO-DONEPEZIL | 5MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80060 |
| TARO-DONEPEZIL | 10MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80063 |
| TARO-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-08-09 | 2019-08-10 | 91261 |
| TARO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-08-09 | 2019-08-10 | 91266 |
| TARO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-08-09 | 2019-08-10 | 91269 |
| TARO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80025 |
| TARO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80028 |
| TARO-PANTOPRAZOLE | Discontinued | 2019-03-29 | 2019-03-29 | 80057 | ||
| TARO-PREGABALIN | 225MG | CAPSULE | Discontinued | 2019-10-04 | 2019-10-04 | 95487 |
| TARO-PREGABALIN | 300MG | CAPSULE | Discontinued | 2020-05-27 | 2020-05-27 | 115811 |
| TARO-QUETIAPINE | 25MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80031 |
| TARO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-03-07 | 2020-03-07 | 108133 |
| TARO-QUETIAPINE | 100MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80034 |
| TARO-QUETIAPINE | 100MG | TABLET | Discontinued | 2020-03-07 | 2020-03-07 | 108136 |